BioGeneration Ventures (BGV) is a venture capital firm that invests in medical and healthcare innovations with a strong scientific basis and the potential to positively impact patients. BGV manages over EUR 250 million across four funds and only invests in solutions that address a significant unmet medical need. The firm works with an ethos founded in novel science and seeks to guide portfolio companies from scientific discovery to product development, leveraging its extensive network and experience in the life sciences industry. The company also invests in partnerships with other investors and has relationships with academic institutions and venture capital firms in the Netherlands, the EU, and the US. By leveraging its knowledge and sector-relevant expertise, BGV aims to transform early-stage biotech companies into attractive investment opportunities.